Infowars.com
The institute recently updated its ‘Frequently Asked Questions’ page about marijuana to include various studies revealing how cannabis “may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow” while also protecting normal, healthy cells.
“A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells,” the NCI stated. “Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.”
Here’s the NCI’s full list:
- Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.
- A study in mice showed that cannabinoids may protect against inflammation of the colon and may have potential in reducing the risk of colon cancer, and possibly in its treatment.
- A laboratory study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that it damaged or killed the cancer cells. The same study of delta-9-THC in mouse models of liver cancer showed that it had antitumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.
- A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
- A laboratory study of cannabidiol (CBD) in human glioma cells showed that when given along withchemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.
Additionally, the National Institute on Drug Abuse also referenced similar, recent studies which revealed “marijuana can kill certain cancer cells and reduce the size of others.”
“Evidence from one animal study suggests that extracts from whole-plant marijuana can shrink one of the most serious types of brain tumors,” the NIDA said in April. “Research in mice showed that these extracts, when used with radiation, increased the cancer-killing effects of the radiation.”
But you’re still going to jail if you get caught using it as medication in most states.
“The worst part is that even marijuana without THC is still illegal, despite having zero ‘high’ effects,” health expert Anthony Gucciardi wrote. “A quick search within the PubMed National Library of Medicine database for ‘marijuana’ turns up a host of studies, highlighting every aspect imaginable regarding the plant in its many forms.”
Despite all these numerous, proven benefits of marijuana, the federal government wants it to remain illegal while the FDA approves expensive prescription drugs with more side effects and far less research.
“The truth? Marijuana is backed by more clinical research than most pharmaceutical drugs,” Gucciardi added.
The National Cancer Institute’s page for Cannabis and Cannabinoids now lists several preclinical trials and studies in which the compounds have shown beneficial medical applications. While these merits come as no surprise for many, the real shocker here is Marijuana still being listed as a Schedule I substance in the eyes of the DEA.
The National Cancer Institute (NCI) is the United State’s primary agency in which cancer research and training is conducted. They are part of a larger umbrella of governmental agencies that comprise the Department of Health and Human Services (HHS). The NCI is largely responsible for the running the National Cancer Program, providing cancer-related information to the public, as well as developing programs and recommendations for the diagnosis, prevention, and treatment of cancer.
Now listed on the the NCI’s Cannabis and Cannabinoids page, which is assumed to be the United State’s official position regarding Marijuana’s potential application in treating cancer, are the following facts:
- Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.
- A study in mice showed that cannabinoids may protect against inflammation of thecolon and may have potential in reducing the risk of colon cancer, and possibly in its treatment.
- A laboratory study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that it damaged or killed the cancer cells. The same study of delta-9-THC inmouse models of liver cancer showed that it had antitumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found innon-small cell lung cancer cells and breast cancer cells.
- A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastaticbreast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
- A laboratory study of cannabidiol (CBD) in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such astemozolomide more effective.
The page also discusses several other potential medical applications for Cannabis and Cannabinoids such as pain relief, appetite stimulation, as well as it being an effective treatment for nausea, anxiety, and depression.
The page concludes by stating the FDA has not approved Cannabis or any Cannabinoids for the treatment of cancer, but that two Cannabinoids (dronabinal and nabilone) are currently approved for the treatment of chemotherapy-related nausea and vomiting.
The NCI’s page on Cannabinoids and Cannabis as a treatment for cancer gives the impression that the currently schedule I substance, Marijuana, holds tremendous potential for medical applications.
“CANNABINOIDS MAY BE ABLE TO KILL CANCER CELLS WHILE PROTECTING NORMAL CELLS”